{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:55:42Z","timestamp":1791024942109,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92369201"],"award-info":[{"award-number":["92369201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejpb.2026.115221","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:34:16Z","timestamp":1787931256000},"page":"115221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and evaluation of a virus-like particle PEDV vaccine based on MS2 bacteriophage"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8422-6573","authenticated-orcid":false,"given":"Yawen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-6217","authenticated-orcid":false,"given":"Shan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8503-8045","authenticated-orcid":false,"given":"Yigang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115221_b0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.virol.2007.03.031","article-title":"J, Porcine aminopeptidase N is a functional receptor for the PEDV coronavirus","volume":"365","author":"Li","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.ejpb.2026.115221_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110113","article-title":"Construction and immune effect evaluation of the S protein heptad repeat-based nanoparticle vaccine against porcine epidemic diarrhea virus","volume":"596","author":"Yang","year":"2024","journal-title":"Virology"},{"key":"10.1016\/j.ejpb.2026.115221_b0015","article-title":"Advances in porcine epidemic diarrhea virus research: genome, epidemiology, vaccines, and detection methods","volume":"20","author":"Zhuang","year":"2025","journal-title":"Discover Nano"},{"key":"10.1016\/j.ejpb.2026.115221_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1396894","article-title":"Research progress of porcine epidemic diarrhea virus S protein","volume":"15","author":"Luo","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejpb.2026.115221_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2025.110412","article-title":"Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies","volume":"604","author":"Fragoso-Saavedra","year":"2025","journal-title":"Virology"},{"key":"10.1016\/j.ejpb.2026.115221_b0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/eji.200425749","article-title":"High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins","volume":"35","author":"Liu","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejpb.2026.115221_b0035","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00705-020-04567-w","article-title":"A flagellin-adjuvanted inactivated porcine epidemic diarrhea virus (PEDV) vaccine provides enhanced immune protection against PEDV challenge in piglets","volume":"165","author":"Xu","year":"2020","journal-title":"Arch. Virol"},{"key":"10.1016\/j.ejpb.2026.115221_b0040","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2025.2508517","article-title":"Virus-like particles: a versatile and effective vaccine platform","volume":"24","author":"Bachmann","year":"2025","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ejpb.2026.115221_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137429","article-title":"Virus-like particles as vaccines for allergen-specific therapy: an overview of current developments","volume":"25","author":"Berreiros-Hortala","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115221_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2026.150208","article-title":"Virus-like particles: bridging immunization and precision drug delivery","author":"Gupta","year":"2026","journal-title":"Gene"},{"key":"10.1016\/j.ejpb.2026.115221_b0055","doi-asserted-by":"crossref","DOI":"10.1111\/cea.70242","article-title":"New generation of allergen immunotherapy using virus\u2010like particles: a comprehensive review","author":"Jacquet","year":"2026","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejpb.2026.115221_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1361323","article-title":"A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza a (H1N1) virus elicits protective immune responses in mice and pigs","volume":"15","author":"Tang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2026.115221_b0065","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.vaccine.2024.01.036","article-title":"Protective efficacy of a plant-produced beta variant rSARS-CoV-2 VLP vaccine in golden Syrian hamsters","volume":"42","author":"Lemmer","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2026.115221_b0070","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01699-24","article-title":"Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9-and type I IFN-dependent pathway","volume":"98","author":"Dai","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.ejpb.2026.115221_b0075","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","article-title":"Nanotechnology in vaccine delivery","volume":"60","author":"Peek","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115221_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12257-022-0107-8","article-title":"Virus-like particles as antiviral vaccine: mechanism, design, and application","volume":"28","author":"Zhang","year":"2023","journal-title":"Biotechnol. Bioprocess. Eng."},{"key":"10.1016\/j.ejpb.2026.115221_b0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2017.09.012","article-title":"A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9","volume":"147","author":"Zhai","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ejpb.2026.115221_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2025.117916","article-title":"A novel triple-display platform based on MS2 virus-like Particles for ultra-sensitive immunoassay of aflatoxin B1","volume":"289","author":"Chen","year":"2025","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.ejpb.2026.115221_b0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jbiotec.2025.09.004","article-title":"A universal single-plasmid, single-promoter system for efficient protein display and RNA encapsulation in MS2 virus-like particles","volume":"408","author":"Chen","year":"2025","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115221_b0100","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1021\/acssynbio.3c00503","article-title":"MS2 virus-like particles as a versatile peptide presentation platform: insights into the deterministic abilities for accommodating heterologous peptide lengths","volume":"12","author":"Dang","year":"2023","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.ejpb.2026.115221_b0105","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2023.06.070","article-title":"The position of Spy Tag\/Catcher system in hepatitis B core protein particles affects the immunogenicity and stability of the synthetic vaccine","volume":"41","author":"Sheng","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2026.115221_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-021-02128-8","article-title":"Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization","volume":"4","author":"Chiba","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejpb.2026.115221_b0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s43246-022-00229-3","article-title":"Programmable polymorphism of a virus-like particle","volume":"3","author":"Biela","year":"2022","journal-title":"Commun. Mater."},{"key":"10.1016\/j.ejpb.2026.115221_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9101128","article-title":"Evaluation of a virus-like nanoparticle porcine circovirus type-2 (PCV2) capsid protein fused with the pig immunoglobulin fc fragment as a novel vaccine candidate against PCV2 in mice","volume":"9","author":"Luo","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ejpb.2026.115221_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128210","article-title":"Hepatitis B core antigen-based trivalent VLP vaccine against porcine viral diarrhea","volume":"74","author":"Sheng","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2026.115221_b0130","article-title":"Surface display of porcine circovirus type 2 antigen protein cap on the spores of Bacillus subtilis 168: an effective mucosal vaccine candidate","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2026.115221_b0135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jcis.2022.07.022","article-title":"Liang Z, Self-assembled aluminum oxyhydroxide nanorices with superior suspension stability for vaccine adjuvant","volume":"627","author":"Bis","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2026.115221_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114890","article-title":"Design-of-experiments based development and in vitro evaluation of a cationic lipid-based triple adjuvanted subunit pertussis vaccine","volume":"217","author":"Mandava","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115221_b0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-025-01124-x","article-title":"Ionizable lipid nanoparticles of mRNA vaccines elicit NF-\u03baB and IRF responses through toll-like receptor 4","volume":"10","author":"Zelkoski","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ejpb.2026.115221_b0150","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-025-01559-z","article-title":"A bacteriophage-based virus-like particle vaccine induces cross-reactive neutralising antibodies against porcine epidemic diarrhoea viruses (PEDV)","volume":"56","author":"Gu","year":"2025","journal-title":"Vet. Res."},{"key":"10.1016\/j.ejpb.2026.115221_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/vetsci12050444","article-title":"Isolation and characterization of porcine epidemic diarrhea virus G2c strains circulating in China from 2021 to 2024","volume":"12","author":"Lu","year":"2025","journal-title":"Vet. Sci."},{"key":"10.1016\/j.ejpb.2026.115221_b0160","doi-asserted-by":"crossref","first-page":"20083","DOI":"10.1021\/acsnano.4c00949","article-title":"Heterologous prime-boost with immunologically orthogonal protein nanoparticles for peptide immunofocusing","volume":"18","author":"Bhattacharya","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2026.115221_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.05.024","article-title":"Single immunization of non-adjuvanted recombinant TTFC-mi3 nanoparticle vaccine elicited a rapid and potent protective immunity against tetanus","volume":"42","author":"He","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2026.115221_b0170","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2231573","article-title":"Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD","volume":"12","author":"Li","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ejpb.2026.115221_b0175","article-title":"Production of promising heat-labile enterotoxin (LT) B subunit-based self-assembled bioconjugate nanovaccines against infectious diseases","volume":"12","author":"Li","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.ejpb.2026.115221_b0180","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1016\/j.vaccine.2017.05.054","article-title":"Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48\/45 based vaccine antigen by SpyTag\/SpyCatcher mediated virus-like display","volume":"35","author":"Singh","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2026.115221_b0185","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/acs.nanolett.6b02948","article-title":"A selection for assembly reveals that a single amino acid mutant of the bacteriophage MS2 coat protein forms a smaller virus-like particle","volume":"16","author":"Asensio","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2026.115221_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198044","article-title":"Porcine circoviruses: current status, knowledge gaps and challenges","volume":"286","author":"Opriessnig","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.ejpb.2026.115221_b0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4142\/jvs.2014.15.3.399","article-title":"Enhancing mucosal immunity in mice by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein delivered with cytosine-phosphate-guanosine oligodeoxynucleotides","volume":"15","author":"Chang","year":"2014","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.ejpb.2026.115221_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/v16060991","article-title":"Development of a ferritin protein nanoparticle vaccine with PRRSV GP5 protein","volume":"16","author":"Chang","year":"2024","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.ejpb.2026.115221_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114878","article-title":"A SpyCatcher-assembled mannosylated nanovaccine elicits potent and cross-protective immunity against monkeypox virus","volume":"217","author":"Yan","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115221_b0210","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28851","article-title":"Profiling the acute phase antibody response against mpox virus in patients infected during the 2022 outbreak","volume":"95","author":"Colavita","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejpb.2026.115221_b0215","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1016\/j.vaccine.2005.01.146","article-title":"HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood","volume":"23","author":"Pinto","year":"2005","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.ejpb.2026.115221_b0220","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1128\/JVI.02018-15","article-title":"Virus-like particle vaccine containing the F protein of respiratory syncytial virus confers protection without pulmonary disease by modulating specific subsets of dendritic cells and effector T cells","volume":"89","author":"Kimkh","year":"2015","journal-title":"J. Virol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:48:57Z","timestamp":1791024537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":44,"alternative-id":["S0939641126002420"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115221","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and evaluation of a virus-like particle PEDV vaccine based on MS2 bacteriophage","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115221"}}